Literature DB >> 28256688

[Learning disorders in neurofibromatosis type 1].

J J Garcia-Penas1.   

Abstract

INTRODUCTION: Neurocognitive deficits and academic learning difficulties are the most common neurologic complication of neurofibromatosis type 1 (NF1) in childhood and can be responsible for significant lifetime morbidity. Children with NF1 show impairments in attention, visual perception, language, executive function, academic skills, and behavior. Studies in animal models suggest that the learning disabilities associated with NF1 are caused by excessive Ras activity that leads to increased gamma-aminobutyric acid (GABA) inhibition and to decreased long-term potentiation. AIM: To describe the frequency, severity, typology, and natural course of specific cognitive deficits in children with NF1. DEVELOPMENT: Cognitive and behavioral disorders affect between 50-80% of all children with NF1. We can define three subtypes of cognitive profiles in children with NF1 and learning disorder, including global learning disorder, specific learning disorder, and isolated attention deficit hyperactivity disorder. The most common cognitive deficits are connected with visual-spatial impairment, however working memory and executive function deficits associated with prefrontal cortex dysfunction are also important.
CONCLUSIONS: There is an extremely high frequency of cognitive problems in children with NF1, making cognitive dysfunction the most common complication to affect quality of life in these children. Early diagnosis and treatment of learning disorders in these patients leads to improved academic outcome.

Entities:  

Mesh:

Year:  2017        PMID: 28256688

Source DB:  PubMed          Journal:  Rev Neurol        ISSN: 0210-0010            Impact factor:   0.870


  4 in total

1.  Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.

Authors:  Alessandro Stella; Patrizia Lastella; Daria Carmela Loconte; Nenad Bukvic; Dora Varvara; Margherita Patruno; Rosanna Bagnulo; Rosaura Lovaglio; Nicola Bartolomeo; Gabriella Serio; Nicoletta Resta
Journal:  Genes (Basel)       Date:  2018-04-17       Impact factor: 4.096

2.  Implications of new understandings of gliomas in children and adults with NF1: report of a consensus conference.

Authors:  Roger J Packer; Antonio Iavarone; David T W Jones; Jaishri O Blakeley; Eric Bouffet; Michael J Fisher; Eugene Hwang; Cynthia Hawkins; Lindsay Kilburn; Tobey MacDonald; Stefan M Pfister; Brian Rood; Fausto J Rodriguez; Uri Tabori; Vijay Ramaswamy; Yuan Zhu; Jason Fangusaro; Stephen A Johnston; David H Gutmann
Journal:  Neuro Oncol       Date:  2020-06-09       Impact factor: 12.300

3.  Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression.

Authors:  Eungu Kang; Yoon-Myung Kim; Yunha Choi; Yena Lee; JunYoung Kim; In Hee Choi; Han-Wook Yoo; Hee Mang Yoon; Beom Hee Lee
Journal:  Orphanet J Rare Dis       Date:  2022-01-29       Impact factor: 4.123

4.  Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.

Authors:  Marie-Laure Armand; Charles Taieb; Aline Bourgeois; Mireille Bourlier; Mohammed Bennani; Christine Bodemer; Pierre Wolkenstein
Journal:  Orphanet J Rare Dis       Date:  2019-05-03       Impact factor: 4.123

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.